文献速递免疫规划传染病防控与疫情报告

两株支气管败血波氏杆菌减毒疫苗候选株在小鼠模型中针对支气管败血波氏杆菌和产毒多杀性巴氏杆菌致死性攻毒提供保护

Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models.
PubMed 文献 · Vaccine · 2022-05-20

本研究将产毒多杀性巴氏杆菌毒素(PMT)的N端或C端片段插入支气管败血波氏杆菌减毒株的aroA基因,构建两株单组分黏膜疫苗候选株Bb-PMTN和Bb-PMTC。小鼠鼻腔免疫后诱导了针对支气管败血波氏杆菌和PMT的抗体及肺内sIgA,对支气管败血波氏杆菌致死性攻毒提供100%保护,对PMT致死性攻毒提供80%~100%保护,且Bb-PMTN免疫原性较Bb-PMTC高1.25倍。

要点

  • 两株减毒株在锥虫大豆肉汤中生长较野生型慢,小鼠模型中毒力较野生型下降161倍。
  • 鼻腔免疫诱导针对支气管败血波氏杆菌和PMT的高水平抗体、血清IFN-γ和IL-10及肺内高滴度sIgA。
  • 对支气管败血波氏杆菌致死性攻毒提供100%保护,对PMT致死性攻毒提供80%~100%保护。

核心结论

  • 支气管败血波氏杆菌减毒株可作为活黏膜载体递送异源抗原;Bb-PMTN和Bb-PMTC是单组分黏膜疫苗候选株。

研究设计与样本

  • 将支气管败血波氏杆菌aroA基因中954 bp片段替换为PMT编码基因toxA的N端930 bp片段(PMTN)或C端900 bp片段(PMTC),构建Bb-PMTN和Bb-PMTC两株减毒株。
  • 用针对全长PMT的多克隆抗体经ELISA证实两株菌表达PMTN和PMTC。
  • 在小鼠模型中经鼻腔免疫Bb-PMTN和Bb-PMTC,评估抗体、细胞因子、sIgA及致死性攻毒保护。

主要发现

  • Bb-PMTN和Bb-PMTC在锥虫大豆肉汤中生长较野生型株慢。
  • 小鼠模型中两株菌毒力较野生型株下降161倍。
  • 鼻腔免疫小鼠诱导针对支气管败血波氏杆菌和PMT的高水平抗体、血清IFN-γ和IL-10及肺内高滴度sIgA。
  • 免疫后对支气管败血波氏杆菌致死性攻毒提供100%保护,对PMT致死性攻毒提供80%~100%保护。
  • Bb-PMTN免疫原性较Bb-PMTC高1.25倍。

临床怎么用

  • 作者认为本研究突显了支气管败血波氏杆菌减毒株作为活黏膜载体递送异源抗原的用途。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dermonecrotic toxin (DNT) is an important bacterial virulence factor produced by the zoonotic pathogens Bordetella bronchiseptica and Pasteurella multocida. This study aims to explore the possibility of expressing different fragments of P. multocida toxin (PMT) in the chromosome of attenuated B. bronchiseptica to generate single-component mucosal vaccine candidates. To achieve this, a 954-bp fragment (basepairs 301 ∼ 1254) of the B. bronchiseptica aroA gene was replaced with an N-terminal, 930-bp fragment (basepairs 1-930; PMTN) or a C-terminal, 900-bp fragment (base pairs 2959 ∼ 3858; PMTC) of the PMT encoding gene toxA. The resulting strains, denoted as Bb-PMTN or Bb-PMTC, expressed PMTN and PMTC, as evidenced by ELISA using polyclonal against full-length of PMT. Phenotypical analyses revealed that Bb-PMTN and Bb-PMTC grew much slower than wild type strains in tryptic soy broth. These strains also displayed significantly decreased 161-fold-virulence compared to the wildtype strains in mouse models. Intranasal immunization of Bb-PMTN and Bb-PMTC in mice induced high levels of antibodies against B. bronchiseptica and PMT, as well as IFN-γ and IL-10 in mouse sera, and most importantly, high titers of sIgA in mouse lungs. Vaccination with these two engineering strains provided 100% protection of mice against lethal challenge with B. bronchiseptica and 80%∼100% protection against lethal challenge with PMT, with Bb-PMTN exhibiting 1.25-fold greater immunogenic efficacy over Bb-PMTC. This study highlights the use of B. bronchiseptica attenuated strains as live mucosal vectors to deliver heterologous antigens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Lin L, Yang J, et al. Two Bordetella bronchiseptica attenuated vaccine candidates confer protection against lethal challenge with B. Bronchiseptica and Pasteurella multocida toxin in mouse models. Vaccine. 2022. PMID: 35599036. doi:10.1016/j.vaccine.2022.05.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。